A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/15/2006	EP1720903A1 Corticotropin-releasing factor receptor 1 (crfr1) agonist polypeptides
11/15/2006	EP1720902A1 Mutein of a bone morphogenetic protein and use thereof
11/15/2006	EP1720900A1 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
11/15/2006	EP1720899A2 Multimerised hiv fusion inhibitors
11/15/2006	EP1720898A2 Antihypertensive peptides from casein hydrolysates
11/15/2006	EP1720893A2 Compositions and methods for the systemic treatment of arthritis
11/15/2006	EP1720586A1 Apparatus and methods for enzymatic debridement of skin lesions
11/15/2006	EP1720579A1 Galactomannans and/or glucomannans for increasing the bioavailability of active substances
11/15/2006	EP1720567A2 Composition and method for the treatment of carcinoma
11/15/2006	EP1720564A1 Methods of treating obesity or diabetes using nt-4/5
11/15/2006	EP1720563A2 Methods and compositions for the treatment of inflammation
11/15/2006	EP1720562A1 Method for treating cardiac remodeling following myocardial injury
11/15/2006	EP1720530A2 Screening method for emulators of neural activity and digestive system using gpr35
11/15/2006	EP1720525A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
11/15/2006	EP1720523A2 Cyclosporin formulations
11/15/2006	EP1720519A1 Lyophilization method to improve excipient crystallization
11/15/2006	EP1720410A1 Compositions and methods for the treatment and clinical remission of psoriasis
11/15/2006	EP1720405A2 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
11/15/2006	EP1615996A4 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
11/15/2006	EP1552301A4 Methods of screening cyclic peptides and identifying targets therefor
11/15/2006	EP1412383B1 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/15/2006	EP1410040B1 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/15/2006	EP1390521A4 Glycopeptide antibiotics
11/15/2006	EP1353968B1 Linear block copolymer
11/15/2006	EP1283869B1 Novel bee venom polypeptides and methods of use thereof
11/15/2006	EP1198560B1 Mammalian adhesion protease
11/15/2006	EP1152731B1 A skin care composition that mediates cell to cell communication
11/15/2006	EP1064372B1 Compounds and methods for therapy and diagnosis of lung cancer
11/15/2006	EP1054950B1 Hiv chemokines
11/15/2006	EP1039921B1 Substantially pure histidine-linked protein polymer conjugates
11/15/2006	EP1008351B1 Carcinostatic agents
11/15/2006	CN1863920A Conjugation of peptides
11/15/2006	CN1863912A A fungal immuromodulatory protein produced by microorganisme and uses there of
11/15/2006	CN1863820A Compounds comprising lpa
11/15/2006	CN1863815A Polypeptides having brain disposition activity and utilization of the same
11/15/2006	CN1863812A Polymorphic antiviral nucleoside compounds
11/15/2006	CN1863558A Polyarginine-modified liposome capable of transferring into nucleus
11/15/2006	CN1863551A Use of PLP with PEG-rMETase in vivo for enhanced efficacy
11/15/2006	CN1863550A Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite
11/15/2006	CN1863549A Conjugates of a polymer and a protein linked by an oxime linking group
11/15/2006	CN1863548A Methods and compositions for treating disorders of the extracellular matrix
11/15/2006	CN1863547A P185-encoding DNA and therapeutical uses thereof
11/15/2006	CN1863546A Methods for treating cardiovascular disease using a soluble ctla4 molecule
11/15/2006	CN1863545A Cytotoxic factors for modulating cell death
11/15/2006	CN1863544A Stabilization of pharmaceutical protein formulations with small peptides
11/15/2006	CN1863531A Treatment for cd5+ b cell lymphoma
11/15/2006	CN1863510A Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
11/15/2006	CN1863506A Methods for preparing oil bodies comprising active ingredients
11/15/2006	CN1863501A Peptide-based conditioners and colorants for hair, skin, and nails
11/15/2006	CN1861634A Dog interferon alpha, preparation process and use thereof
11/15/2006	CN1861630A Active segment of HER2/neu with Herstatin interaction, coding gene and application thereof
11/15/2006	CN1861195A Fowl vaccine immunopotentiator of chicken interleuken-18, and its application
11/15/2006	CN1861191A Application of human sDR5 protein as medicine to treat virus hepatitis B
11/15/2006	CN1861190A Application of anion exchange protein 1 and gene used as target for preparing medicine to treat alimentary canal tumor
11/15/2006	CN1861189A Medicinal composition for eliminating infection and reduplication of influenza-virus
11/15/2006	CN1861188A Aerosol contg. met-enkephalin
11/15/2006	CN1861064A Medicine composition contg. sodium azulene sulfonate and L-glutamine water-soluble precursor
11/15/2006	CN1861036A Preserving a hemoglobin blood substitute with a transparent overwrap
11/15/2006	CN1284798C Poly thymosin-alpha 1, its composition, its preparation method and application
11/15/2006	CN1284600C Biological fluid film of recombined human keratinized cell growth factor-2 and its preparing process
11/15/2006	CN1284523C Method of coating fine particle with lipid film
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006	US7135617 Diacylglycerol acyl transferase proteins
11/14/2006	US7135612 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
11/14/2006	US7135559 Proteins and novel genes encoding the same
11/14/2006	US7135556 NPC1L1 (NPC3) and methods of use thereof
11/14/2006	US7135553 Polymerizing hemoglobin with glutaraldehyde in solution, treating the polymerized hemoglobin to elaborate tetramer and removing tetramer from the polymerized hemoglobin solution
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135548 Having antimicrobial activity
11/14/2006	US7135547 Peptide conjugated anti-cancer prodrugs
11/14/2006	US7135463 inhibiting the growth of a cancerous cell by contacting cell with an effective amount of a RhoB protein, or a variant of the RhoB protein; alone or in combination with additional anti-cancer agents, such as cytotoxic agents (e.g., 5-flurouracil)
11/14/2006	US7135462 Hepatitis C virus inhibitors
11/14/2006	US7135461 Retro-inverso peptides derived from interleukin-6
11/14/2006	US7135459 Using fibroblast growth factor (zFGF5) compositions to proliferate chondrocytes and their progenitors and to induce deposits of cartilage; injuries; defects; neurological disorders such as stroke; bone disorcers; antiischemic agents
11/14/2006	US7135458 Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
11/14/2006	US7135457 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
11/14/2006	US7135456 Glial mitogenic factors, their preparation and use
11/14/2006	US7135455 Topically administering cyclosporin A in a rectal suppository to treat inflammatory bowel disease and ulcerative colitis
11/14/2006	US7135454 Use of SLURP-1 compositions for treating schizophrenia
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/14/2006	US7135452 Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
11/14/2006	US7135338 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism
11/14/2006	US7135334 Stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more
11/14/2006	US7135324 Viral recombinases, related articles, and methods of use thereof
11/14/2006	US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
11/14/2006	US7135312 Genberation of preferential oligonucleotide; obtain nucleotide sequence template, incubate with polymerase and reaction micture, propagate, separate and recover oligonucleotide
11/14/2006	US7135307 Gamma three protease
11/14/2006	US7135305 Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype
11/14/2006	US7135303 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
11/14/2006	US7135286 Pharmaceutical and diagnostic business systems and methods
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	US7135190 Biodegradable and water soluble polyesterether block polymers possessing reverse thermal gelation properties, used for drug delivery of genes, peptides, anticancer or antiproliferative agents
11/14/2006	US7135189 Compositions and techniques for localized therapy
11/14/2006	US7135188 Methods and compositions for immunotherapy of cancer
11/14/2006	US7135185 Conserved motif of hepatitis C virus E2/NS1 region
11/14/2006	US7135182 Administration of substrates for transglutaminases or antibodies against such substrates; identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans
11/14/2006	US7135181 Method for down-regulation of amyloid
11/14/2006	US7135179 Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof
11/14/2006	US7135178 Methods of treating disseminated intravascular coagulation using anti-TNF antibodies
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells

1 ... 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 ... 3163